Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 11-12/2014

01.06.2014 | original article

Evaluation of oxidant and antioxidant status and relation with prolidase in systemic sclerosis

verfasst von: MD Esen Savas, Nur Aksoy, Yavuz Pehlivan, Zeynel Abidin Sayiner, Zeynel Abidin Öztürk, Suzan Tabur, Mustafa Örkmez, Ahmet Mesut Onat

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 11-12/2014

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Purpose

Systemic sclerosis (SSc) is a disease characterized by fibrosis of the skin and organs; it is associated with diffuse fibroproliferative microangiopathy and autoimmune background. The studies have shown that the production of excessive free radicals and increased collagen synthesis by the fibroblasts play an important role in the pathophysiology of SSc. Prolidase is an important marker in collagen turnover. We aimed to compare total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), and prolidase levels of SSc patients and healthy controls. We also investigated the relationship between prolidase and oxidative stress.

Methods

A total of 38 SSc patients and 33 healthy volunteers were included in the study. Serum TAS, TOS, and prolidase activity were evaluated in the groups.

Results

It was found that the TOS and OSI levels of patients were higher than those in the control group (P = 0.012 and 0.015, respectively), whereas TAS was not significantly different between groups (P = 0.451). Prolidase activity was lower in patients than in controls (P = 0.008). There was a weak correlation between prolidase and OSI in patients. It was found that TAS was lower by marginal significance in the patients with lung and gastrointestinal tract (GT) involvement than the patients without those (P = 0.067 and 0.059, respectively).

Conclusions

Our data suggest that oxidative stress is increased in SSc. TAS is decreased in patients with lung and GT involvement. These results support that antioxidant treatment may be useful in SSc, especially in patients with lung and GT involvement. Antioxidant treatment may prevent organ involvement in SSc. TAS may be a marker that predicts the risk of involvement of a specific organ. In addition, prolidase may be a marker of SSc.
Literatur
1.
Zurück zum Zitat Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol. 2005;26:587–95. PubMedCrossRef Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol. 2005;26:587–95. PubMedCrossRef
2.
Zurück zum Zitat Gabrielli A, Svegliati S, Moroncini G, Pomponio G, Santillo M, Avvedimento EV. Oxidative stress and the pathogenesis of scleroderma: the Murrel’s hypothesis revisited. Semin Immunopathol. 2008;30:329–37. PubMedCrossRef Gabrielli A, Svegliati S, Moroncini G, Pomponio G, Santillo M, Avvedimento EV. Oxidative stress and the pathogenesis of scleroderma: the Murrel’s hypothesis revisited. Semin Immunopathol. 2008;30:329–37. PubMedCrossRef
3.
Zurück zum Zitat Murrell GAC, Francis MJO, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J. 1990;265:659–65. PubMedCentralPubMed Murrell GAC, Francis MJO, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J. 1990;265:659–65. PubMedCentralPubMed
4.
Zurück zum Zitat Hinchcliff M, Varga J. Systemic sclerosis/scleroderma: a treatable multisystem disease. Am Fam Physician. 2008;78:961–8. PubMed Hinchcliff M, Varga J. Systemic sclerosis/scleroderma: a treatable multisystem disease. Am Fam Physician. 2008;78:961–8. PubMed
5.
Zurück zum Zitat Eckes B, Mauch C, Huppe G, Krieg T. Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem J. 1996;315:549–54. PubMedCentralPubMed Eckes B, Mauch C, Huppe G, Krieg T. Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem J. 1996;315:549–54. PubMedCentralPubMed
6.
Zurück zum Zitat Myara I, Charpentier C, Lemonnier A. Minireview: prolidase and prolidase deficiency. Life Sci. 1984;34:1985–98. PubMedCrossRef Myara I, Charpentier C, Lemonnier A. Minireview: prolidase and prolidase deficiency. Life Sci. 1984;34:1985–98. PubMedCrossRef
7.
Zurück zum Zitat Surazynski A, Miltyk W, Palka J, Phang JM. Prolidase-dependent regulation of collagen biosynthesis. Amino Acids. 2008;35:731–8. PubMedCrossRef Surazynski A, Miltyk W, Palka J, Phang JM. Prolidase-dependent regulation of collagen biosynthesis. Amino Acids. 2008;35:731–8. PubMedCrossRef
8.
Zurück zum Zitat Masi AT, Rodnan GP, Medsger TA, Jr, Altman RD, D’Angelo WA, Fries JF, et al. Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum. 1980;23:581–90. CrossRef Masi AT, Rodnan GP, Medsger TA, Jr, Altman RD, D’Angelo WA, Fries JF, et al. Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum. 1980;23:581–90. CrossRef
9.
Zurück zum Zitat Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281–5. PubMed Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281–5. PubMed
10.
Zurück zum Zitat Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D’Angelo S, et al. European multicenter study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis. 2001;60:592–8. PubMedCentralPubMedCrossRef Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D’Angelo S, et al. European multicenter study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis. 2001;60:592–8. PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Medsger TA, Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999;26:2159–67. PubMed Medsger TA, Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999;26:2159–67. PubMed
12.
Zurück zum Zitat Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by praline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta. 1982;125:193–205. PubMedCrossRef Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by praline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta. 1982;125:193–205. PubMedCrossRef
13.
Zurück zum Zitat Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem. 1952;199:91–5. PubMed Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem. 1952;199:91–5. PubMed
14.
Zurück zum Zitat Erel OA. Novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112–9. PubMedCrossRef Erel OA. Novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112–9. PubMedCrossRef
15.
Zurück zum Zitat Koc S, Aksoy N, Bilinc H, Duygu F, Uysal IO, Ekinci A, et al. Paraoxonase and arylesterase activity and total oxidative/antioxidative status in patients with chronic adenotonsillitis. Int J Pediatr Otorhinolaryngol. 2011;75:1364–7. PubMedCrossRef Koc S, Aksoy N, Bilinc H, Duygu F, Uysal IO, Ekinci A, et al. Paraoxonase and arylesterase activity and total oxidative/antioxidative status in patients with chronic adenotonsillitis. Int J Pediatr Otorhinolaryngol. 2011;75:1364–7. PubMedCrossRef
16.
Zurück zum Zitat Erel OA. New automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103–11. PubMedCrossRef Erel OA. New automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103–11. PubMedCrossRef
17.
Zurück zum Zitat Kosecik M, Erel O, Sevinc E, Selek S. Increased oxidative stress in children exposed to passive smoking. Int J Cardiol. 2005;100:61–4. PubMedCrossRef Kosecik M, Erel O, Sevinc E, Selek S. Increased oxidative stress in children exposed to passive smoking. Int J Cardiol. 2005;100:61–4. PubMedCrossRef
18.
Zurück zum Zitat Yamamoto T, Katayama I, Nishioka K. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol. 1998;25(2):314–7. PubMed Yamamoto T, Katayama I, Nishioka K. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol. 1998;25(2):314–7. PubMed
19.
Zurück zum Zitat Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, et al. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum. 2001;44(11):2653–64. PubMedCrossRef Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, et al. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum. 2001;44(11):2653–64. PubMedCrossRef
20.
Zurück zum Zitat Stein CM, Tanner SB, Awad JA, Roberts LJ 2nd, Morrow JD. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum. 1996;39(7):1146–50. PubMedCrossRef Stein CM, Tanner SB, Awad JA, Roberts LJ 2nd, Morrow JD. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum. 1996;39(7):1146–50. PubMedCrossRef
21.
Zurück zum Zitat Herrick AL, Matucci CM. The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol. 2001;19(1):4–8. Review. PubMed Herrick AL, Matucci CM. The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol. 2001;19(1):4–8. Review. PubMed
22.
Zurück zum Zitat Simonini G, Pignone A, Generini S, Falcini F, Cerinic MM. Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology. 2000;155(1–3):1–15. PubMed Simonini G, Pignone A, Generini S, Falcini F, Cerinic MM. Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology. 2000;155(1–3):1–15. PubMed
23.
Zurück zum Zitat Tikly M, Channa K, Theodorou P, Gulumian M. Lipid peroxidation and trace elements in systemic sclerosis. Clin Rheumatol. 2006;25(3):320–4. PubMedCrossRef Tikly M, Channa K, Theodorou P, Gulumian M. Lipid peroxidation and trace elements in systemic sclerosis. Clin Rheumatol. 2006;25(3):320–4. PubMedCrossRef
24.
Zurück zum Zitat Kalin R, Righi A, Del Rosso A, Bagchi D, Generini S, Cerinic MM, et al. Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. Free Radic Res. 2002;36(8):819–25. PubMedCrossRef Kalin R, Righi A, Del Rosso A, Bagchi D, Generini S, Cerinic MM, et al. Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. Free Radic Res. 2002;36(8):819–25. PubMedCrossRef
25.
Zurück zum Zitat Ogawa F, Shimizu K, Muroi E, Hara T, Sato S. Increasing levels of serum antioxidant status, total antioxidant power, in systemic sclerosis. Clin Rheumatol. 2011;30:921–5. PubMedCrossRef Ogawa F, Shimizu K, Muroi E, Hara T, Sato S. Increasing levels of serum antioxidant status, total antioxidant power, in systemic sclerosis. Clin Rheumatol. 2011;30:921–5. PubMedCrossRef
26.
Zurück zum Zitat Rosato E, Rossi C, Molinaro I, Giovannetti A, Pisarri S, Salsano F. Long-term N-acetylcysteine therapy in systemic sclerosis interstitial lung disease: a retrospective study. Int J Immunopathol Pharmacol. 2011;24(3):727–33. PubMed Rosato E, Rossi C, Molinaro I, Giovannetti A, Pisarri S, Salsano F. Long-term N-acetylcysteine therapy in systemic sclerosis interstitial lung disease: a retrospective study. Int J Immunopathol Pharmacol. 2011;24(3):727–33. PubMed
27.
Zurück zum Zitat Ogawa F, Shimizu K, Hara T, Muroi E, Komura K, Takenaka M, et al. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage. Arch Dermatol Res. 2010;302:27–35. PubMedCrossRef Ogawa F, Shimizu K, Hara T, Muroi E, Komura K, Takenaka M, et al. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage. Arch Dermatol Res. 2010;302:27–35. PubMedCrossRef
28.
Zurück zum Zitat Musellim B, Ikitimur H, Uzun H, Ongen G. The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement. Rheumatol Int. 2006;27(2):163–7. PubMedCrossRef Musellim B, Ikitimur H, Uzun H, Ongen G. The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement. Rheumatol Int. 2006;27(2):163–7. PubMedCrossRef
29.
Zurück zum Zitat Gabriele S, Alberto P, Sergio G, Fernanda F, Marco MC. Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology. 2000;155:1–15. PubMedCrossRef Gabriele S, Alberto P, Sergio G, Fernanda F, Marco MC. Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology. 2000;155:1–15. PubMedCrossRef
30.
Zurück zum Zitat Denton CP, Bunce TD, Dorado MB, Roberts Z, Wilson H, Howell K. Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud’s phenomenon. Rheumatology (Oxford). 1999;38(4):309–15. CrossRef Denton CP, Bunce TD, Dorado MB, Roberts Z, Wilson H, Howell K. Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud’s phenomenon. Rheumatology (Oxford). 1999;38(4):309–15. CrossRef
31.
Zurück zum Zitat Ocakci A, Coskun O, Tumkaya L, Kanter M, Gurel A, Hosnuterd M, et al. Beneficial effects of ebselen on corrosive esophageal burns of rats. Int J Pediatr Otorhinolaryngol. 2006;70(1):45–52. PubMedCrossRef Ocakci A, Coskun O, Tumkaya L, Kanter M, Gurel A, Hosnuterd M, et al. Beneficial effects of ebselen on corrosive esophageal burns of rats. Int J Pediatr Otorhinolaryngol. 2006;70(1):45–52. PubMedCrossRef
32.
Zurück zum Zitat Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int. 2007;27:339–44. PubMedCrossRef Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int. 2007;27:339–44. PubMedCrossRef
33.
Zurück zum Zitat Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis. 2008;19(5):319–25. PubMedCrossRef Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis. 2008;19(5):319–25. PubMedCrossRef
34.
Zurück zum Zitat Shrinath M, Walter JH, Haeney M, Couriel J, Lewis M, Herrick A. Prolidase deficiency and systemic lupus erythematosus. Arch Dis Child. 1997;76(5):441–4. PubMedCentralPubMedCrossRef Shrinath M, Walter JH, Haeney M, Couriel J, Lewis M, Herrick A. Prolidase deficiency and systemic lupus erythematosus. Arch Dis Child. 1997;76(5):441–4. PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat Langberg H, Skovgaard D, Asp S, Kjaer M. Time pattern of exercise-induced changes in type I collagen turnover after prolonged endurance exercise in humans. Calcif Tissue Int. 2000;67(1):41–4. PubMedCrossRef Langberg H, Skovgaard D, Asp S, Kjaer M. Time pattern of exercise-induced changes in type I collagen turnover after prolonged endurance exercise in humans. Calcif Tissue Int. 2000;67(1):41–4. PubMedCrossRef
Metadaten
Titel
Evaluation of oxidant and antioxidant status and relation with prolidase in systemic sclerosis
verfasst von
MD Esen Savas
Nur Aksoy
Yavuz Pehlivan
Zeynel Abidin Sayiner
Zeynel Abidin Öztürk
Suzan Tabur
Mustafa Örkmez
Ahmet Mesut Onat
Publikationsdatum
01.06.2014
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 11-12/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-014-0534-4